Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,163
Recruiting: 2,261
Ph III recruiting: 270
Growth YoY: +12.5%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 1,251–1,264 of 1,264 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05955521	Exosome as the Prognostic and Predictive Biomarker in EBC Patients	active not recruiting	N/A	200	Samsung Medical CenterOTHER	1	Jul 21, 2023	clinicaltrials
NCT05951127	Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC(LEO)	active not recruiting	N/A	141	Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER	1	Jul 18, 2023